About Critical Limb Ischemia
In the United States, approximately 600,000 endovascular procedures were performed on the lower limbs in 2014; these procedures are projected to increase to almost 1 million by 2020.1 Individuals with diabetes are at greater risk for severe PAD and are 10-30 times more likely to have an amputation.2 There is a 1-year post-amputation mortality rate of 50% for PAD-related lower extremity amputations.5
Terumo delivers a portfolio of tools for the solution to this growing problem.
Peripheral Artery Disease (PAD) characterized by fatty build up that blocks normal blood flow in the arteries, has become an increasingly common diagnosis in the US.3 Approximately 8 million people in the United States have PAD.4 Terumo Interventional Systems offers a unique suite of products to meet the special challenges of PAD cases, particularly those involving the difficult to access lower extremities. Our products have been specifically developed in collaboration with leading physicians and are designed to be easy-to-use to provide reliable access and navigation of tortuous vessels enabling physicians to cross lesions with confidence, which in turn may help save limbs and improve lives.
1. Source: The Millennium Research Group Peripheral Vascular Devices US 2015 Market Analysis RPUS11PV14 Page 98
2. Source: http://care.diabetesjournals.org/content/27/7/1598.long
3. Source: http://www.heart.org/HEARTORG/Conditions/More/PeripheralArteryDisease/About-Peripheral-Artery-Disease-PAD_UCM_301301_Article.jsp
4. Source: http://www.cdc.gov/DHDSP/data_statistics/fact_sheets/fs_PAD.htm
5. Source: http://www.sciencedirect.com/science/article/pii/S1078588413002256
CLI with TERUMO